Randomized trial · people

HGH: 9.78 cm/year growth vs 10.10 on weekly somatrogon

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In young children with growth hormone deficiency, daily somatropin and a once-weekly long-acting version produced similar first-year growth with similar side effect rates.

Kind
Randomized trial
Studied in
People
Number studied
228
Published
2022
Journal
J Clin Endocrinol Metab

What they tested

The team tested whether once-weekly somatrogon, a long-acting growth hormone, works at least as well and as safely as once-daily somatropin in young children with growth hormone deficiency.

How the study was done

An open-label, randomized phase 3 trial in 228 children who had not yet reached puberty, had growth hormone deficiency and had never been treated with growth hormone. They got either weekly somatrogon (0.66 mg/kg/week arm) or daily somatropin (0.24 mg/kg/week arm) for 12 months. Open-label means families and doctors knew which drug was given.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking HGH? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At 12 months, children on somatrogon grew at 10.10 cm/year and those on somatropin at 9.78 cm/year, a difference of 0.33 (95% CI: -0.24, 0.89). The whole range stayed above the preset noninferiority margin of -1.8 cm/year, so weekly somatrogon counted as no worse than daily somatropin. Growth rate at 6 months and change in height standard deviation score (how height compares with peers) at 6 and 12 months were similar in both groups. Mild to moderate side effects showed up at similar rates: 78.9% on somatrogon and 79.1% on somatropin.

What it doesn’t show

It ran for only 12 months and was open-label, so knowing the treatment could have colored reports. It included only prepubertal children new to growth hormone, so it says nothing about adults, teens or people switching drugs.

The paper

Deal et al. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. J Clin Endocrinol Metab. 2022.

The compound

More studies on HGH

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking HGH? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo